The Hexanucleotide Hex
Elie Dolgin • October 19, 2017
For years, researchers missed the most common genetic cause of ALS. Now they're on an accelerated track to treat it.
Continue reading here.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.